Actuate Therapeutics (ACTU) Insider Trading & Ownership $8.67 -0.23 (-2.58%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Actuate Therapeutics (NASDAQ:ACTU) Insider Buying and Selling ActivityNumber OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$4 MNumber OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$374,991.00 Get ACTU Insider Trade Alerts Want to know when executives and insiders are buying or selling Actuate Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ACTU Insider Buying and Selling by Quarter Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Actuate Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/14/2024Equity Cof Lp BiosDirectorBuy500,000$8.00$4,000,000.00 8/14/2024Leslie W KreisMajor ShareholderSell24,999$9.00$224,991.00 8/14/2024Todd S ThomsonInsiderSell18,750$8.00$150,000.00 (Data available from 1/1/2013 forward) ACTU Insider Trading Activity - Frequently Asked Questions Who is on Actuate Therapeutics's Insider Roster? The list of insiders at Actuate Therapeutics includes Equity Cof Lp Bios, Leslie W Kreis, and Todd S Thomson. Learn more on insiders at ACTU. Which Actuate Therapeutics insiders have been buying company stock? The following insider purchased ACTU shares in the last 24 months: Equity Cof Lp Bios ($4,000,000.00). How much insider buying is happening at Actuate Therapeutics? Insiders have purchased a total of 500,000 ACTU shares in the last 24 months for a total of $4,000,000.00 bought. Which Actuate Therapeutics insiders have been selling company stock? The following insiders have sold ACTU shares in the last 24 months: Leslie W Kreis ($224,991.00), and Todd S Thomson ($150,000.00). How much insider selling is happening at Actuate Therapeutics? Insiders have sold a total of 43,749 Actuate Therapeutics shares in the last 24 months for a total of $374,991.00 sold. Actuate Therapeutics Key ExecutivesMr. Daniel M. Schmitt (Age 62)CEO, President & Director Compensation: $520kDr. Andrew P. Mazar Ph.D. (Age 62)Co-Founder & COO Compensation: $607.5kDr. Alan Kozikowski Ph.D. (Age 73)Scientific Founder and Advisor Mr. Paul J. Lytle CPA (Age 56)Chief Financial Officer More Insider Trading Tools from MarketBeat Related Companies TRDA Insider Buying DNTH Insider Buying CRMD Insider Buying TECX Insider Buying PHAT Insider Buying ORIC Insider Buying ANAB Insider Buying STOK Insider Buying TRML Insider Buying IMNM Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ACTU) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actuate Therapeutics Please log in to your account or sign up in order to add this asset to your watchlist. Share Actuate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
